Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Eating Well (or at Least Not terribly) at Fast Food Resturants
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Continuous Glucose Monitoring with DEXCOM's

Deb Ruppert

Continuous Glucose Monitoring with DEXCOM's "The Seven"

Merino intensive skin care products

Judy Reber

Merino intensive skin care products

Mind Over (Foot) Matters

Brigitta Rice, MS, RPh, CHES

Mind Over (Foot) Matters

View all Videos…
Diabetic Ketoacidosis Archives
Browse the Diabetic Ketoacidosis Archives
Subscribe to the Complications & Care RSS Feed

Diabetic Ketoacidosis

Complications & Care RSS Feed RSS
Updated 64 weeks ago
 
Type 1 Diabetes Researchers Reach Important Milestone
news
Type 1 Diabetes Researchers Reach Important Milestone

Type 1 Diabetes TrialNet, an international network of researchers exploring ways to prevent and delay the progression of type 1 diabetes, has reached an important milestone: screening 100,000 people to detect who among is at risk of developing type 1 diabetes. This is a major achievement because it has helped researchers better predict who will develop diabetes and when it will require treatment. Earlier diagnosis helps patients avoid a severe, life-threatening condition called diabetic ketoacidosis. 

Comments 0 comments - Mar 28, 2012 - * * * * *

Nova Diabetes Care Announces DECA Sponsorship Nova Diabetes Care Announces DECA Sponsorship

Comments 1 comment - Feb 29, 2012 - * * * * *

FDA OKs Sale of Combo Drug JANUMET® XR
news
FDA OKs Sale of Combo Drug JANUMET® XR

The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin and extended-release metformin. The drug is the fourth oral type 2 diabetes treatment introduced by Merck, which also sells JANUVIA, JANUMET, and JUVISYNC.

Comments 0 comments - Feb 6, 2012 - * * * * *

Animas Receives Warning Letter From the FDA
news
Animas Receives Warning Letter From the FDA

Animas Corporation, a division of Johnson & Johnson that manufactures insulin pumps, has been reprimanded by the FDA for not reporting serious problems resulting from use of its equipment. The parent company was warned that it could face fines and more for selling faulty insulin pumps and failing to disclose serious injuries to diabetic patients who used the OneTouch Ping and 2020 insulin pumps. According to reports, J&J continued to sell the pumps even after the company knew that some had failed.

Comments 1 comment - Jan 29, 2012 - * * * * *

 
©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.